Biosimilar Testing and Development Services Market Report

Europe Biosimilar Testing and Development Services Market Size, Status and Forecast 2014-2026

  • POSTDATE：Jun 21, 2020
  • PAGES：215
  • REPORT CODE：GMM577180
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Biosimilar Testing and Development Services market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 11.7% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Biosimilar Testing and Development Services Market Segmentations:

    By Player:

    • SGS

    • Eurofins Scientific

    • Exova

    • Source BioScience

    • Medistri

    • Pace Analytical Services

    • Charles River Laboratories

    • Pharmaceutical Product Development

    • Intertek Group

    • Sigma-Aldrich

    By Type:

    • Effector Binding

    • ELISA

    • Kinetic Binding Assays

    • ADCC & CDC Cell-Based Assays

    By End-User:

    • PK assay

    • Tiered Immunogenicity testing

    • NAb assays

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Biosimilar Testing and Development Services Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Biosimilar Testing and Development Services Market Size and Growth Rate of Effector Binding from 2014 to 2026

    • 1.3.2 Europe Biosimilar Testing and Development Services Market Size and Growth Rate of ELISA from 2014 to 2026

    • 1.3.3 Europe Biosimilar Testing and Development Services Market Size and Growth Rate of Kinetic Binding Assays from 2014 to 2026

    • 1.3.4 Europe Biosimilar Testing and Development Services Market Size and Growth Rate of ADCC & CDC Cell-Based Assays from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Biosimilar Testing and Development Services Market Size and Growth Rate of PK assay from 2014 to 2026

    • 1.4.2 Europe Biosimilar Testing and Development Services Market Size and Growth Rate of Tiered Immunogenicity testing from 2014 to 2026

    • 1.4.3 Europe Biosimilar Testing and Development Services Market Size and Growth Rate of NAb assays from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Biosimilar Testing and Development Services Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Biosimilar Testing and Development Services Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Biosimilar Testing and Development Services Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Biosimilar Testing and Development Services Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Biosimilar Testing and Development Services Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Biosimilar Testing and Development Services Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Biosimilar Testing and Development Services Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Biosimilar Testing and Development Services Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Biosimilar Testing and Development Services Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biosimilar Testing and Development Services Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Biosimilar Testing and Development Services Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Biosimilar Testing and Development Services Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Biosimilar Testing and Development Services Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Biosimilar Testing and Development Services by Major Types

      • 3.4.1 Market Size and Growth Rate of Effector Binding

      • 3.4.2 Market Size and Growth Rate of ELISA

      • 3.4.3 Market Size and Growth Rate of Kinetic Binding Assays

      • 3.4.4 Market Size and Growth Rate of ADCC & CDC Cell-Based Assays

    4 Segmentation of Biosimilar Testing and Development Services Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Biosimilar Testing and Development Services by Major End-Users

      • 4.4.1 Market Size and Growth Rate of PK assay for Construction

      • 4.4.2 Market Size and Growth Rate of Tiered Immunogenicity testing for Construction

      • 4.4.3 Market Size and Growth Rate of NAb assays for Construction

    5 Market Analysis by Major Regions

    • 5.1 Europe Biosimilar Testing and Development Services Production Analysis by Top Regions

    • 5.2 Europe Biosimilar Testing and Development Services Consumption Analysis by Top Regions

    • 5.3 Europe Biosimilar Testing and Development Services Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Biosimilar Testing and Development Services Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Biosimilar Testing and Development Services Production, Import, Consumption and Export Analysis

      • 5.3.3 France Biosimilar Testing and Development Services Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Biosimilar Testing and Development Services Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Biosimilar Testing and Development Services Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Biosimilar Testing and Development Services Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Biosimilar Testing and Development Services Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Biosimilar Testing and Development Services Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Biosimilar Testing and Development Services Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biosimilar Testing and Development Services Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Biosimilar Testing and Development Services Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Biosimilar Testing and Development Services Production, Import, Consumption and Export Analysis

    6 Product Circulation of Biosimilar Testing and Development Services Market among Top Countries

    • 6.1 Top 5 Export Countries in Biosimilar Testing and Development Services Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Biosimilar Testing and Development Services Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Biosimilar Testing and Development Services Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Biosimilar Testing and Development Services Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Biosimilar Testing and Development Services Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Biosimilar Testing and Development Services Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Biosimilar Testing and Development Services Landscape Analysis

    • 7.1 Germany Biosimilar Testing and Development Services Landscape Analysis by Major Types

    • 7.2 Germany Biosimilar Testing and Development Services Landscape Analysis by Major End-Users

    8. UK Biosimilar Testing and Development Services Landscape Analysis

    • 8.1 UK Biosimilar Testing and Development Services Landscape Analysis by Major Types

    • 8.2 UK Biosimilar Testing and Development Services Landscape Analysis by Major End-Users

    9. France Biosimilar Testing and Development Services Landscape Analysis

    • 9.1 France Biosimilar Testing and Development Services Landscape Analysis by Major Types

    • 9.2 France Biosimilar Testing and Development Services Landscape Analysis by Major End-Users

    10. Italy Biosimilar Testing and Development Services Landscape Analysis

    • 10.1 Italy Biosimilar Testing and Development Services Landscape Analysis by Major Types

    • 10.2 Italy Biosimilar Testing and Development Services Landscape Analysis by Major End-Users

    11. Spain Biosimilar Testing and Development Services Landscape Analysis

    • 11.1 Spain Biosimilar Testing and Development Services Landscape Analysis by Major Types

    • 11.2 Spain Biosimilar Testing and Development Services Landscape Analysis by Major End-Users

    12. Poland Biosimilar Testing and Development Services Landscape Analysis

    • 12.1 Poland Biosimilar Testing and Development Services Landscape Analysis by Major Types

    • 12.2 Poland Biosimilar Testing and Development Services Landscape Analysis by Major End-Users

    13. Russia Biosimilar Testing and Development Services Landscape Analysis

    • 13.1 Russia Biosimilar Testing and Development Services Landscape Analysis by Major Types

    • 13.2 Russia Biosimilar Testing and Development Services Landscape Analysis by Major End-Users

    14. Switzerland Biosimilar Testing and Development Services Landscape Analysis

    • 14.1 Switzerland Biosimilar Testing and Development Services Landscape Analysis by Major Types

    • 14.2 Switzerland Biosimilar Testing and Development Services Landscape Analysis by Major End-Users

    15. Turkey Biosimilar Testing and Development Services Landscape Analysis

    • 15.1 Turkey Biosimilar Testing and Development Services Landscape Analysis by Major Types

    • 15.2 Turkey Biosimilar Testing and Development Services Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biosimilar Testing and Development Services Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biosimilar Testing and Development Services Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biosimilar Testing and Development Services Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biosimilar Testing and Development Services Landscape Analysis by Top Countries

      • 16.3.1 Denmark Biosimilar Testing and Development Services Market Volume and Growth Rate

      • 16.3.2 Finland Biosimilar Testing and Development Services Market Volume and Growth Rate

      • 16.3.3 Norway Biosimilar Testing and Development Services Market Volume and Growth Rate

      • 16.3.4 Sweden Biosimilar Testing and Development Services Market Volume and Growth Rate

      • 16.3.6 Iceland Biosimilar Testing and Development Services Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Biosimilar Testing and Development Services Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Biosimilar Testing and Development Services Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Biosimilar Testing and Development Services Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Biosimilar Testing and Development Services Landscape Analysis by Top Countries

      • 17.3.1 Belgium Biosimilar Testing and Development Services Market Volume and Growth Rate

      • 17.3.2 Netherlands Biosimilar Testing and Development Services Market Volume and Growth Rate

      • 17.3.3 Luxembourg Biosimilar Testing and Development Services Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Biosimilar Testing and Development Services Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Biosimilar Testing and Development Services Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Biosimilar Testing and Development Services Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Biosimilar Testing and Development Services Landscape Analysis by Top Countries

      • 18.3.1 Estonia Biosimilar Testing and Development Services Market Volume and Growth Rate

      • 18.3.2 Latvia Biosimilar Testing and Development Services Market Volume and Growth Rate

      • 18.3.3 Lithuania Biosimilar Testing and Development Services Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 SGS

      • 19.1.1 SGS Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Eurofins Scientific

      • 19.2.1 Eurofins Scientific Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Exova

      • 19.3.1 Exova Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Source BioScience

      • 19.4.1 Source BioScience Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Medistri

      • 19.5.1 Medistri Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Pace Analytical Services

      • 19.6.1 Pace Analytical Services Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Charles River Laboratories

      • 19.7.1 Charles River Laboratories Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Pharmaceutical Product Development

      • 19.8.1 Pharmaceutical Product Development Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Intertek Group

      • 19.9.1 Intertek Group Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Sigma-Aldrich

      • 19.10.1 Sigma-Aldrich Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    The List of Tables and Figures (Totals 97 Figures and 131 Tables)

    • Figure Product Picture

    • Figure Biosimilar Testing and Development Services Market Size and Growth Rate of Effector Binding Market, 2015 - 2026 (USD Million)

    • Figure Biosimilar Testing and Development Services Market Size and Growth Rate of ELISA Market, 2015 - 2026 (USD Million)

    • Figure Biosimilar Testing and Development Services Market Size and Growth Rate of Kinetic Binding Assays Market, 2015 - 2026 (USD Million)

    • Figure Biosimilar Testing and Development Services Market Size and Growth Rate of ADCC & CDC Cell-Based Assays Market, 2015 - 2026 (USD Million)

    • Figure Biosimilar Testing and Development Services Market Size and Growth Rate of PK assay from 2014 to 2026

    • Figure Biosimilar Testing and Development Services Market Size and Growth Rate of Tiered Immunogenicity testing from 2014 to 2026

    • Figure Biosimilar Testing and Development Services Market Size and Growth Rate of NAb assays from 2014 to 2026

    • Figure Germany Biosimilar Testing and Development Services Market Size and Growth Rate from 2014 to 2026

    • Figure UK Biosimilar Testing and Development Services Market Size and Growth Rate from 2014 to 2026

    • Figure France Biosimilar Testing and Development Services Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Biosimilar Testing and Development Services Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Biosimilar Testing and Development Services Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Biosimilar Testing and Development Services Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Biosimilar Testing and Development Services Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Biosimilar Testing and Development Services Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Biosimilar Testing and Development Services Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Biosimilar Testing and Development Services Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Biosimilar Testing and Development Services Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biosimilar Testing and Development Services Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Biosimilar Testing and Development Services Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Biosimilar Testing and Development Services Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Biosimilar Testing and Development Services Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Biosimilar Testing and Development Services Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Biosimilar Testing and Development Services Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Biosimilar Testing and Development Services Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Biosimilar Testing and Development Services Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Biosimilar Testing and Development Services Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Biosimilar Testing and Development Services Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Biosimilar Testing and Development Services Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Biosimilar Testing and Development Services Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Biosimilar Testing and Development Services Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Biosimilar Testing and Development Services Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Biosimilar Testing and Development Services Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Biosimilar Testing and Development Services

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Biosimilar Testing and Development Services by Different Types from 2014 to 2026

    • Table Consumption Share of Biosimilar Testing and Development Services by Different Types from 2014 to 2026

    • Figure Biosimilar Testing and Development Services Market Size and Growth Rate of Effector Binding Market, 2015 - 2026 (USD Million)

    • Figure Biosimilar Testing and Development Services Market Size and Growth Rate of ELISA Market, 2015 - 2026 (USD Million)

    • Figure Biosimilar Testing and Development Services Market Size and Growth Rate of Kinetic Binding Assays Market, 2015 - 2026 (USD Million)

    • Figure Biosimilar Testing and Development Services Market Size and Growth Rate of ADCC & CDC Cell-Based Assays Market, 2015 - 2026 (USD Million)

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Biosimilar Testing and Development Services by Different End-Users from 2014 to 2026

    • Table Consumption Share of Biosimilar Testing and Development Services by Different End-Users from 2014 to 2026

    • Figure Biosimilar Testing and Development Services Market Size and Growth Rate of PK assay from 2014 to 2026

    • Figure Biosimilar Testing and Development Services Market Size and Growth Rate of Tiered Immunogenicity testing from 2014 to 2026

    • Figure Biosimilar Testing and Development Services Market Size and Growth Rate of NAb assays from 2014 to 2026

    • Table Europe Biosimilar Testing and Development Services Production by Major Regions

    • Table Europe Biosimilar Testing and Development Services Production Share by Major Regions

    • Figure Europe Biosimilar Testing and Development Services Production Share by Major Countries and Regions in 2014

    • Table Europe Biosimilar Testing and Development Services Consumption by Major Regions

    • Table Europe Biosimilar Testing and Development Services Consumption Share by Major Regions

    • Table Germany Biosimilar Testing and Development Services Production, Import, Consumption and Export Analysis

    • Table UK Biosimilar Testing and Development Services Production, Import, Consumption and Export Analysis

    • Table France Biosimilar Testing and Development Services Production, Import, Consumption and Export Analysis

    • Table Italy Biosimilar Testing and Development Services Production, Import, Consumption and Export Analysis

    • Table Spain Biosimilar Testing and Development Services Production, Import, Consumption and Export Analysis

    • Table Poland Biosimilar Testing and Development Services Production, Import, Consumption and Export Analysis

    • Table Russia Biosimilar Testing and Development Services Production, Import, Consumption and Export Analysis

    • Table Switzerland Biosimilar Testing and Development Services Production, Import, Consumption and Export Analysis

    • Table Turkey Biosimilar Testing and Development Services Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biosimilar Testing and Development Services Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Biosimilar Testing and Development Services Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Biosimilar Testing and Development Services Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Biosimilar Testing and Development Services Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Biosimilar Testing and Development Services Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Biosimilar Testing and Development Services Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Biosimilar Testing and Development Services Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Biosimilar Testing and Development Services Consumption by Types from 2014 to 2026

    • Table Germany Biosimilar Testing and Development Services Consumption Share by Types from 2014 to 2026

    • Table Germany Biosimilar Testing and Development Services Consumption by End-Users from 2014 to 2026

    • Table Germany Biosimilar Testing and Development Services Consumption Share by End-Users from 2014 to 2026

    • Table UK Biosimilar Testing and Development Services Consumption by Types from 2014 to 2026

    • Table UK Biosimilar Testing and Development Services Consumption Share by Types from 2014 to 2026

    • Table UK Biosimilar Testing and Development Services Consumption by End-Users from 2014 to 2026

    • Table UK Biosimilar Testing and Development Services Consumption Share by End-Users from 2014 to 2026

    • Table France Biosimilar Testing and Development Services Consumption by Types from 2014 to 2026

    • Table France Biosimilar Testing and Development Services Consumption Share by Types from 2014 to 2026

    • Table France Biosimilar Testing and Development Services Consumption by End-Users from 2014 to 2026

    • Table France Biosimilar Testing and Development Services Consumption Share by End-Users from 2014 to 2026

    • Table Italy Biosimilar Testing and Development Services Consumption by Types from 2014 to 2026

    • Table Italy Biosimilar Testing and Development Services Consumption Share by Types from 2014 to 2026

    • Table Italy Biosimilar Testing and Development Services Consumption by End-Users from 2014 to 2026

    • Table Italy Biosimilar Testing and Development Services Consumption Share by End-Users from 2014 to 2026

    • Table Spain Biosimilar Testing and Development Services Consumption by Types from 2014 to 2026

    • Table Spain Biosimilar Testing and Development Services Consumption Share by Types from 2014 to 2026

    • Table Spain Biosimilar Testing and Development Services Consumption by End-Users from 2014 to 2026

    • Table Spain Biosimilar Testing and Development Services Consumption Share by End-Users from 2014 to 2026

    • Table Poland Biosimilar Testing and Development Services Consumption by Types from 2014 to 2026

    • Table Poland Biosimilar Testing and Development Services Consumption Share by Types from 2014 to 2026

    • Table Poland Biosimilar Testing and Development Services Consumption by End-Users from 2014 to 2026

    • Table Poland Biosimilar Testing and Development Services Consumption Share by End-Users from 2014 to 2026

    • Table Russia Biosimilar Testing and Development Services Consumption by Types from 2014 to 2026

    • Table Russia Biosimilar Testing and Development Services Consumption Share by Types from 2014 to 2026

    • Table Russia Biosimilar Testing and Development Services Consumption by End-Users from 2014 to 2026

    • Table Russia Biosimilar Testing and Development Services Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Biosimilar Testing and Development Services Consumption by Types from 2014 to 2026

    • Table Switzerland Biosimilar Testing and Development Services Consumption Share by Types from 2014 to 2026

    • Table Switzerland Biosimilar Testing and Development Services Consumption by End-Users from 2014 to 2026

    • Table Switzerland Biosimilar Testing and Development Services Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Biosimilar Testing and Development Services Consumption by Types from 2014 to 2026

    • Table Turkey Biosimilar Testing and Development Services Consumption Share by Types from 2014 to 2026

    • Table Turkey Biosimilar Testing and Development Services Consumption by End-Users from 2014 to 2026

    • Table Turkey Biosimilar Testing and Development Services Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biosimilar Testing and Development Services Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biosimilar Testing and Development Services Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biosimilar Testing and Development Services Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biosimilar Testing and Development Services Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biosimilar Testing and Development Services Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biosimilar Testing and Development Services Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Biosimilar Testing and Development Services Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Biosimilar Testing and Development Services Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Biosimilar Testing and Development Services Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Biosimilar Testing and Development Services Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Biosimilar Testing and Development Services Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Biosimilar Testing and Development Services Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Biosimilar Testing and Development Services Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Biosimilar Testing and Development Services Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Biosimilar Testing and Development Services Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Biosimilar Testing and Development Services Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Biosimilar Testing and Development Services Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Biosimilar Testing and Development Services Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Biosimilar Testing and Development Services Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Biosimilar Testing and Development Services Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Biosimilar Testing and Development Services Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Biosimilar Testing and Development Services Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Biosimilar Testing and Development Services Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Biosimilar Testing and Development Services Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Biosimilar Testing and Development Services Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Biosimilar Testing and Development Services Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Biosimilar Testing and Development Services Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Biosimilar Testing and Development Services Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Biosimilar Testing and Development Services Market Volume and Growth Rate from 2014 to 2026

    • Table SGS Profiles

    • Table SGS Production, Value, Price, Gross Margin 2014-2019

    • Table SGS Product benchmarking

    • Table SGS Strategic initiatives

    • Table SGS SWOT analysis

    • Table Eurofins Scientific Profiles

    • Table Eurofins Scientific Production, Value, Price, Gross Margin 2014-2019

    • Table Eurofins Scientific Product benchmarking

    • Table Eurofins Scientific Strategic initiatives

    • Table Eurofins Scientific SWOT analysis

    • Table Exova Profiles

    • Table Exova Production, Value, Price, Gross Margin 2014-2019

    • Table Exova Product benchmarking

    • Table Exova Strategic initiatives

    • Table Exova SWOT analysis

    • Table Source BioScience Profiles

    • Table Source BioScience Production, Value, Price, Gross Margin 2014-2019

    • Table Source BioScience Product benchmarking

    • Table Source BioScience Strategic initiatives

    • Table Source BioScience SWOT analysis

    • Table Medistri Profiles

    • Table Medistri Production, Value, Price, Gross Margin 2014-2019

    • Table Medistri Product benchmarking

    • Table Medistri Strategic initiatives

    • Table Medistri SWOT analysis

    • Table Pace Analytical Services Profiles

    • Table Pace Analytical Services Production, Value, Price, Gross Margin 2014-2019

    • Table Pace Analytical Services Product benchmarking

    • Table Pace Analytical Services Strategic initiatives

    • Table Pace Analytical Services SWOT analysis

    • Table Charles River Laboratories Profiles

    • Table Charles River Laboratories Production, Value, Price, Gross Margin 2014-2019

    • Table Charles River Laboratories Product benchmarking

    • Table Charles River Laboratories Strategic initiatives

    • Table Charles River Laboratories SWOT analysis

    • Table Pharmaceutical Product Development Profiles

    • Table Pharmaceutical Product Development Production, Value, Price, Gross Margin 2014-2019

    • Table Pharmaceutical Product Development Product benchmarking

    • Table Pharmaceutical Product Development Strategic initiatives

    • Table Pharmaceutical Product Development SWOT analysis

    • Table Intertek Group Profiles

    • Table Intertek Group Production, Value, Price, Gross Margin 2014-2019

    • Table Intertek Group Product benchmarking

    • Table Intertek Group Strategic initiatives

    • Table Intertek Group SWOT analysis

    • Table Sigma-Aldrich Profiles

    • Table Sigma-Aldrich Production, Value, Price, Gross Margin 2014-2019

    • Table Sigma-Aldrich Product benchmarking

    • Table Sigma-Aldrich Strategic initiatives

    • Table Sigma-Aldrich SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US